Lonza
Julian Mass is a seasoned finance professional with extensive experience in the biotechnology and energy sectors. Currently serving as Senior Director and Head of Finance at Lonza Biologics Visp since April 2019, Julian has held various leadership roles within Lonza, including Director and Associate Director of Finance for the Drug Product Services Business Unit. Prior to this, Julian worked at GE Power in Global Operations Finance & Controlling and held a financial controlling position at Alstom. Julian's academic achievements include a Chartered Global Management Accountant (CGMA) qualification from CIMA and master's and bachelor's degrees in management and business administration from the University of Hohenheim.
This person is not in any teams
This person is not in any offices
Lonza
66 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.